Echeverria, Gloria V. http://orcid.org/0000-0002-3772-9298
Cai, Shirong
Tu, Yizheng
Shao, Jiansu
Powell, Emily
Redwood, Abena B.
Jiang, Yan
McCoy, Aaron
Rinkenbaugh, Amanda L. http://orcid.org/0000-0003-3276-6863
Lau, Rosanna
Trevarton, Alexander J. http://orcid.org/0000-0002-1404-0199
Fu, Chunxiao
Gould, Rebekah
Ravenberg, Elizabeth E.
Huo, Lei
Candelaria, Rosalind
Santiago, Lumarie
Adrada, Beatriz E.
Lane, Deanna L.
Rauch, Gaiane M.
Yang, Wei T.
White, Jason B. http://orcid.org/0000-0001-7140-545X
Chang, Jeffrey T. http://orcid.org/0000-0002-4578-5636
Moulder, Stacy L.
Symmans, W. Fraser http://orcid.org/0000-0002-1526-184X
Hilsenbeck, Susan G. http://orcid.org/0000-0002-7962-673X
Piwnica-Worms, Helen http://orcid.org/0000-0003-4210-6738
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RP150148, RP160710, R200009, RP160710, RP170668, RP160710)
U.S. Department of Health & Human Services | National Institutes of Health (K22CA241113-01)
American Cancer Society (130423-PF-17-067-01-TBG)
Article History
Received: 18 May 2022
Accepted: 13 December 2022
First Online: 10 January 2023
Competing interests
: S.L.M. and E.E.R are employees of Eli Lilly. W.F.S. owns founder stock in Delphi Diagnostics and publicly traded stock in IONIS Pharmaceuticals and Eiger BioPharmaceuticals; is a consultant/advisor to Merck, Astra Zeneca; is co-inventor of pending patent “Targeted Measure of Transcriptional Activity Related to Hormone Receptors”, United States, Provisional Patent Application Serial No. 62/329,774; has received support for unrelated research from Pfizer; has nothing to disclose for travel, accommodations, expenses; and is an uncompensated scientific advisor to Delphi Diagnostics. R.L. is co-inventor of pending patent “Targeted Measure of Transcriptional Activity Related to Hormone Receptors”, United States, Provisional Patent Application Serial No. 62/329,774. C.F is co-inventor of pending patent “Targeted Measure of Transcriptional Activity Related to Hormone Receptors”, United States, Provisional Patent Application Serial No. 62/329,774. W.Y. receives Elsevier book royalties. All other authors have no competing financial or non-financial interests.